Novavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement

• Post author:GHIAA Admin
• Post published:September 10, 2021
• Post category:

Continue ReadingNovavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement

US Department of Defense – Janssen, COVID-19 Vaccine Large Scale Manufacturing Agreement

• Post author:GHIAA Admin
• Post published:September 9, 2021
• Post category:

Continue ReadingUS Department of Defense – Janssen, COVID-19 Vaccine Large Scale Manufacturing Agreement

CEPI – Valneva, Chikungunya Vaccine Funding Agreement

• Post author:GHIAA Admin
• Post published:August 23, 2021
• Post category:

Continue ReadingCEPI – Valneva, Chikungunya Vaccine Funding Agreement

AUTM Model Inter-Institutional Agreement

• Post author:GHIAA Admin
• Post published:August 19, 2021
• Post category:

Continue ReadingAUTM Model Inter-Institutional Agreement

ATI – Regeneron, COVID-19 Antibodies Manufacturing Agreement

• Post author:GHIAA Admin
• Post published:August 19, 2021
• Post category:

Continue ReadingATI – Regeneron, COVID-19 Antibodies Manufacturing Agreement

Gilead – Indian Generic Manufacturers, HCV License Agreement

• Post author:GHIAA Admin
• Post published:August 18, 2021
• Post category:

Continue ReadingGilead – Indian Generic Manufacturers, HCV License Agreement

CEPI – Novavax, COVID-19 Vaccine Funding Agreement

• Post author:GHIAA Admin
• Post published:August 10, 2021
• Post category:

Continue ReadingCEPI – Novavax, COVID-19 Vaccine Funding Agreement

Fiocruz – AstraZeneca, COVID-19 Technological Order Agreement

• Post author:GHIAA Editor
• Post published:July 1, 2021
• Post category:

Continue ReadingFiocruz – AstraZeneca, COVID-19 Technological Order Agreement

NIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement

• Post author:GHIAA Admin
• Post published:June 30, 2021
• Post category:

Continue ReadingNIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement